Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, a move investors said eases some concerns ...

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

Here, six house and techno artists provide a look into what it’s like being a tastemaker spinning at Time Warp. They discuss their favorite memories, why the event is special to them and more.

in New York City in December. Cluster of cops appear to be stationed in the area surrounding the hotel and metal barriers line the entrances of the venue, which are flanked by several private ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

The first day of the J.P. Morgan Healthcare Conference is in the books, featuring high-profile deal announcements from Johnson & Johnson, Eli Lilly ... Thompson in New York City.

in New York City, US. (Photo source: Reuters) Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check.

Eli Lilly’s market capitalisation was just over $750bn as of early Friday afternoon in New York. It is expected to generate about $46bn in sales this year, much of this from Mounjaro and Zepbound.

Hyderabad: Eli Lilly and Company on Thursday said it plans to set up a new global capability centre (GCC) in Hyderabad. To be called Lilly Capability Centre India (LCCI), the GCC will be US pharma ...

Shares of Eli Lilly & Co. were headed for their worst ... MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.